Ecocert will no longer certify CBD-containing products as organic
In a letter addressed to those who have applied for organic certification for their CBD-containing products, Ecocert, the certifying body for the organic label, has announced that it will no longer grant its label for CBD products.
At issue is MILDECA's new position, having been contradicted by the Kanavape ruling, Ecocert has updated what it believes to be the correct legislative framework surrounding CBD in France. Ecocert stresses that it is reacting to requests from the French authorities, based in particular on this passage on the Novel Food from MILDECA :
«The marketing of foodstuffs is governed by Regulation (EC) No. 178/2002, according to which no foodstuff may be placed on the market if it is injurious to health or unfit for human consumption, and by Regulation (EU) No. 2015 / 2283 on novel foods: products for which no consumption history can be established prior to 1997 are subject to evaluation by the European Food Safety Authority (EFSA) and to pre-market authorization. To date, CBD and hemp extracts are considered to have no history of consumption and therefore cannot be incorporated into food products.»
Novel Food challenged by EIHA
However, the classification of CBD as a Novel Food has already been called into question by hemp associations, in particular by the’European Industrial Hemp Association (EIHA), the association representing European hemp-related interests.
Unreservedly contesting this classification, EIHA has also submitted 4 files to classify 4 formulations of CBD Novel Food products which covers all CBD-related products. If the request succeeds, it would once again undermine the MILDECA's position.
In the meantime, Ecocert will withdraw organic certification from hemp products containing CBD.
-
Cannabis in Europe4 weeks ago
Bosnia and Herzegovina Continues to Roll Out Medical Cannabis Following Its Legalization
-
Cannabis in France3 weeks ago
France Submits the Long-Awaited Decree on the Reimbursement of Medical Cannabis to the Council of State
-
Cannabis in the U.S.4 weeks ago
The DEA Begins Hearings on the Federal Rescheduling of Cannabis
-
Business3 weeks ago
China Invests $10 Million in Medical Cannabis in Lebanon
-
Cannabis in Thailand4 weeks ago
Thailand Threatens Cannabis Shops with Severe Penalties
-
Business4 weeks ago
The British medical cannabis market is expected to exceed 140,000 patients by 2026
-
Cannabis in Australia2 weeks ago
South Australia is working to identify more water-efficient hemp varieties
-
Exchange4 weeks ago
Glass House will be the second U.S. cannabis company to list on the New York Stock Exchange


You must be logged in to post a comment Login